Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.31m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

3 Feb 2021 16:52

RNS Number : 9236N
Anpario PLC
03 February 2021
Β 

3 February 2021

ANPARIO PLC("Anpario" or "the Company")

Β 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND PERSONS CLOSELY ASSOCIATED WITH THEM

Β 

Anpario plc ("Anpario") announces that on 1 February 2021, 19,338 options were exercised into Ordinary shares of 23 pence each ("Ordinary Shares") under the Company's 2017 Save As You Earn Scheme by employees and PDMRs. As such 19,338 Ordinary Shares (the "SAYE Shares") have been issued by the Company.

Β 

The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares is satisfied via the Company's existing block listing.

Β 

On 1 February 2021 the Company was notified by the following directors of the Company of the exercise of options of ordinary shares of 23 pence each in the Company ("Ordinary Shares"), exercised on that day, being Ordinary Shares granted under the Company's SAYE at an option price of 334.00 pence.

Β 

Director

Status

Holding pre options exercised

SAYE Options exercised

Holding post exercise

% holding post exercise

Richard Edwards

Chief Executive Officer

210,702

2,694

213.396

0.9%

Karen Prior

Group Finance Director

74,751

2,694

77,445

0.3%

Β 

Enquiries:

Β 

Anpario plc

Richard Edwards, Chief Executive Officer +44(0) 777 6417 129Karen Prior, Finance Director +44(0) 1909 537380

Β 

Peel Hunt LLP +44 (0)20 7418 8900

Adrian TrimmingsAndrew Clark

Will Bell

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

Richard Edwards

2

Reason for the notification

a)

Position/status

Β 

Chief Executive Officer

b)

Initial notification/Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary Shares of 23 pence each in the Company ("Ordinary Shares")

Β 

ISIN GB00B3NWT178

Β 

Β 

b)

Nature of the transaction

Β 

Exercise of options

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

334.00p

2,694

Β 

d)

Aggregated information

Β 

Price(s)

Volume(s)

334.00p

Β 

2,694

Β 

e)

Date of the transaction

Β 

1 February 2021

f)

Place of the transaction

Β 

Β 

Off market

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

Karen Prior

2

Reason for the notification

a)

Position/status

Β 

Group Finance Director

b)

Initial notification/Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary Shares of 23 pence each in the Company ("Ordinary Shares")Β 

Β 

ISIN GB00B3NWT178

Β 

b)

Nature of the transaction

Β 

Exercise of options

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

334.00 p

2,694

Β 

d)

Aggregated information

Β 

Price(s)

Volume(s)

334.00 p

Β 

2,694

Β 

e)

Date of the transaction

Β 

1 February 2021

f)

Place of the transaction

Β 

Β 

Off market

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKZGGZVFMGMZM
Date   Source Headline
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSAcquisition of Bio-Vet Inc.
13th Sep 20247:00 amRNSNotice of Investor Presentation
11th Sep 20247:00 amRNSInterim results
14th Aug 202411:22 amRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSBlock listing Interim Review
25th Jun 20242:34 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Statement
12th Jun 20244:11 pmRNSHolding(s) in Company
24th May 202410:04 amRNSPosting of Annual Report and Notice of AGM
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report
5th Sep 202212:38 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.